QA: Mylan INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000069499_2014_Mylan_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000069499, Mylan INC

  xvar xval
0 AssetsCurrent 4,471,260,000
1 IntangibleAssetsNetIncludingGoodwill 6,806,012,000
2 PropertyPlantAndEquipmentNet 1,663,076,000
3 remainder_Assets 2,295,993,000
4 LiabilitiesCurrent 2,956,070,000
5 LiabilitiesNoncurrent 8,851,834,000
6 remainder_Liabilities 468,530,000
7 CostOfGoodsAndServicesSold 3,866,438,929
8 SellingGeneralAndAdministrativeExpense 1,413,311,733
9 ResearchAndDevelopmentExpense 530,916,050
10 remainder_Expenses 416,020,325
11 remainder_Revenues 6,927,267,441
12 remainder_NetIncome -11,493,444
13 remainder_ComprehensiveNetIncome -935,009,000
  yvar yval
0 Assets 15,236,341,000
1 Liabilities 12,276,434,000
2 Expenses 6,226,687,037
3 Revenues 6,927,267,441
4 StockholdersEquity 2,959,907,000
5 NetIncome 689,086,960
6 ComprehensiveNetIncome 221,582,460
7 BaseVar 20,806,615,961
8 EconomicCapitalRatiobeforeLimitedLiability 0.485
9 EconomicCapitalRatio 1.87

Edgar->Model Mapping

Feature Distribution

Change over Time